Purchase Order 75N91020P00712

<p>The National Cancer Institute awarded a purchase order to Novogene Corporation Inc. for $24,750.00 in testing services on July 27, 2020, with completion targeted for February 22, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services. The order is firm fixed price with no set-aside category applied.</p>

Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order totaling $24,864 by the National Cancer Institute, a component of the Department of Health and Human Services' National Institutes of Health. The contract calls for Novogene to provide laboratory testing services in Bethesda, Maryland, in support of the agency's biomedical research efforts. As a previous provider of genomic sequencing and bioinformatics services under over 100 federal...

<p>The National Institute of Nursing Research awarded a purchase order to Novogene Corporation Inc. for $24,700 on March 31, 2020, with completion by April 30, 2020. Work is performed in Chula Vista, California. Novogene is a minority-owned small business. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institute on Aging awarded a purchase order to Novogene Corporation Inc. for $19,370.00 on March 2, 2021, for human mRNA sequencing services. The order, a firm fixed-price acquisition with no set-aside, is scheduled for completion by June 4, 2021. Work is performed in Chula Vista, California. Novogene is a minority-owned small business specializing in genomic sequencing and bioinformatics services.</p>

<p>The National Institute on Aging issued a purchase order to Novogene Corporation Inc. on May 6, 2020, valued at $13,000.00 for genomic sequencing and bioinformatics services. The awardee is a minority-owned small business. Work is performed in Chula Vista, California. The order carries a firm fixed price and an ultimate completion date of September 30, 2020.</p>

Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...

<p>The National Institute of Child Health and Human Development awarded a purchase order to Novogene Corporation Inc. for $3,886.00 on August 17, 2017. Novogene is a minority-owned small business. Performance occurs in Chula Vista, California. The order runs from August 17, 2017 through August 16, 2018 under firm fixed pricing. No set-aside designation was applied to this purchase order.</p>

<p>The Department of Interior's Office of Logistics and Acquisition Operations issued a purchase order to Novogene Corporation Inc. on August 29, 2017, with a ceiling value of $14,750.00. The order expires August 31, 2018. Novogene, a minority-owned small business, will perform the work at its facility in Chula Vista, California. The order is firm fixed price with no set-aside designation applied.</p>

The U.S. government awarded a $7,065 firm fixed-price purchase order to Novogene Corporation Inc. on August 30, 2018, for RNA sequencing, library preparation, and six gigabytes of raw sequencing data per sample services. The contract, based on Novogene's quote dated July 9, 2018, was issued under the simplified acquisition threshold procedures for purchases under $25,000 and did not utilize a small business set-aside designation. Work was completed by April 16, 2019, with services performed in...

The U.S. government awarded a $2,868.00 purchase order to Novogene Corporation Inc., a minority-owned small business specializing in genomic sequencing and bioinformatics services. The contract, issued on January 13, 2021, with completion targeted for July 14, 2021, covers RNA sequencing services to be performed in Chula Vista, California. This firm fixed-price purchase order was funded by a civilian federal agency and was not designated as a set-aside contract. Novogene, headquartered in...